Global epidemiology of Neisseria gonorrhoeae in infertile populations

Protocol for a systematic review

Hiam Chemaitelly, Harfouche Manale, Karel Blondeel, Thabo Christopher Matsaseng, James Kiarie, Igor Toskin, Laith Aburaddad

Research output: Contribution to journalReview article

Abstract

Introduction A key target of the WHO's € Global Health Sector Strategy on sexually transmitted infections, 2016-2021' is achieving 90% reduction in Neisseria gonorrhoeae (gonorrhoea for short) incidence globally by 2030. Though untreated, gonorrhoea has been linked to infertility, the epidemiology of this infection in infertile populations remains poorly understood and somewhat a neglected area of reproductive health. Our proposed systematic review aims to fill this gap by characterising comprehensively gonorrhoea infection in infertile populations globally. Methods and analysis All available studies of gonorrhoea infection in infertile populations, including infertility clinic attendees, will be systematically reviewed informed by Cochrane Collaboration guidelines. Findings will be reported following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Data sources will be searched using broad index terms exploded to cover all subheadings and free text terms with no language or year restriction. Any epidemiological measure in infertile populations based on primary data will be eligible for inclusion. Measures based on different assay types will be extracted as separate studies for different analyses. Only one biospecimen type per assay type will be considered based on a predefined priority order. Samples including fewer than 10 participants or assessing infection in the upper genital tract will be excluded. Quality assessments will be conducted for all measures included in the review. Meta-analyses will be implemented using DerSimonian-Laird random effect models to estimate the mean prevalence of gonorrhoea in infertile populations globally, and stratified by WHO region, assay type, sex, infertility type, infertility diagnosis, among other factors. Detailed heterogeneity assessment will be performed, and potential sources of between-study heterogeneity will be explored using meta-regression. Review will be conducted from 26 March 2018 to 28 July 2019. Ethics and dissemination An institutional review board clearance is not required as all data are publicly available. The findings will be disseminated through a peer-reviewed publication and international scientific meetings/workshops with key stakeholders. PROSPERO registration number CRD42018102934

Original languageEnglish
Article numbere025808
JournalBMJ Open
Volume9
Issue number5
DOIs
Publication statusPublished - 1 May 2019

Fingerprint

Neisseria gonorrhoeae
Gonorrhea
Epidemiology
Infertility
Population
Infection
Meta-Analysis
Guidelines
Information Storage and Retrieval
Research Ethics Committees
Reproductive Health
Sexually Transmitted Diseases
Ethics
Publications
Language
Education
Incidence

Keywords

  • epidemiology
  • Gonorrhea
  • infertility
  • Neisseria gonorrhoeae
  • prevalence
  • sexually transmitted infections

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Global epidemiology of Neisseria gonorrhoeae in infertile populations : Protocol for a systematic review. / Chemaitelly, Hiam; Manale, Harfouche; Blondeel, Karel; Matsaseng, Thabo Christopher; Kiarie, James; Toskin, Igor; Aburaddad, Laith.

In: BMJ Open, Vol. 9, No. 5, e025808, 01.05.2019.

Research output: Contribution to journalReview article

Chemaitelly, Hiam ; Manale, Harfouche ; Blondeel, Karel ; Matsaseng, Thabo Christopher ; Kiarie, James ; Toskin, Igor ; Aburaddad, Laith. / Global epidemiology of Neisseria gonorrhoeae in infertile populations : Protocol for a systematic review. In: BMJ Open. 2019 ; Vol. 9, No. 5.
@article{092f1dff91554051a55d6056d2eb18b9,
title = "Global epidemiology of Neisseria gonorrhoeae in infertile populations: Protocol for a systematic review",
abstract = "Introduction A key target of the WHO's € Global Health Sector Strategy on sexually transmitted infections, 2016-2021' is achieving 90{\%} reduction in Neisseria gonorrhoeae (gonorrhoea for short) incidence globally by 2030. Though untreated, gonorrhoea has been linked to infertility, the epidemiology of this infection in infertile populations remains poorly understood and somewhat a neglected area of reproductive health. Our proposed systematic review aims to fill this gap by characterising comprehensively gonorrhoea infection in infertile populations globally. Methods and analysis All available studies of gonorrhoea infection in infertile populations, including infertility clinic attendees, will be systematically reviewed informed by Cochrane Collaboration guidelines. Findings will be reported following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Data sources will be searched using broad index terms exploded to cover all subheadings and free text terms with no language or year restriction. Any epidemiological measure in infertile populations based on primary data will be eligible for inclusion. Measures based on different assay types will be extracted as separate studies for different analyses. Only one biospecimen type per assay type will be considered based on a predefined priority order. Samples including fewer than 10 participants or assessing infection in the upper genital tract will be excluded. Quality assessments will be conducted for all measures included in the review. Meta-analyses will be implemented using DerSimonian-Laird random effect models to estimate the mean prevalence of gonorrhoea in infertile populations globally, and stratified by WHO region, assay type, sex, infertility type, infertility diagnosis, among other factors. Detailed heterogeneity assessment will be performed, and potential sources of between-study heterogeneity will be explored using meta-regression. Review will be conducted from 26 March 2018 to 28 July 2019. Ethics and dissemination An institutional review board clearance is not required as all data are publicly available. The findings will be disseminated through a peer-reviewed publication and international scientific meetings/workshops with key stakeholders. PROSPERO registration number CRD42018102934",
keywords = "epidemiology, Gonorrhea, infertility, Neisseria gonorrhoeae, prevalence, sexually transmitted infections",
author = "Hiam Chemaitelly and Harfouche Manale and Karel Blondeel and Matsaseng, {Thabo Christopher} and James Kiarie and Igor Toskin and Laith Aburaddad",
year = "2019",
month = "5",
day = "1",
doi = "10.1136/bmjopen-2018-025808",
language = "English",
volume = "9",
journal = "BMJ Open",
issn = "2044-6055",
publisher = "BMJ Publishing Group",
number = "5",

}

TY - JOUR

T1 - Global epidemiology of Neisseria gonorrhoeae in infertile populations

T2 - Protocol for a systematic review

AU - Chemaitelly, Hiam

AU - Manale, Harfouche

AU - Blondeel, Karel

AU - Matsaseng, Thabo Christopher

AU - Kiarie, James

AU - Toskin, Igor

AU - Aburaddad, Laith

PY - 2019/5/1

Y1 - 2019/5/1

N2 - Introduction A key target of the WHO's € Global Health Sector Strategy on sexually transmitted infections, 2016-2021' is achieving 90% reduction in Neisseria gonorrhoeae (gonorrhoea for short) incidence globally by 2030. Though untreated, gonorrhoea has been linked to infertility, the epidemiology of this infection in infertile populations remains poorly understood and somewhat a neglected area of reproductive health. Our proposed systematic review aims to fill this gap by characterising comprehensively gonorrhoea infection in infertile populations globally. Methods and analysis All available studies of gonorrhoea infection in infertile populations, including infertility clinic attendees, will be systematically reviewed informed by Cochrane Collaboration guidelines. Findings will be reported following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Data sources will be searched using broad index terms exploded to cover all subheadings and free text terms with no language or year restriction. Any epidemiological measure in infertile populations based on primary data will be eligible for inclusion. Measures based on different assay types will be extracted as separate studies for different analyses. Only one biospecimen type per assay type will be considered based on a predefined priority order. Samples including fewer than 10 participants or assessing infection in the upper genital tract will be excluded. Quality assessments will be conducted for all measures included in the review. Meta-analyses will be implemented using DerSimonian-Laird random effect models to estimate the mean prevalence of gonorrhoea in infertile populations globally, and stratified by WHO region, assay type, sex, infertility type, infertility diagnosis, among other factors. Detailed heterogeneity assessment will be performed, and potential sources of between-study heterogeneity will be explored using meta-regression. Review will be conducted from 26 March 2018 to 28 July 2019. Ethics and dissemination An institutional review board clearance is not required as all data are publicly available. The findings will be disseminated through a peer-reviewed publication and international scientific meetings/workshops with key stakeholders. PROSPERO registration number CRD42018102934

AB - Introduction A key target of the WHO's € Global Health Sector Strategy on sexually transmitted infections, 2016-2021' is achieving 90% reduction in Neisseria gonorrhoeae (gonorrhoea for short) incidence globally by 2030. Though untreated, gonorrhoea has been linked to infertility, the epidemiology of this infection in infertile populations remains poorly understood and somewhat a neglected area of reproductive health. Our proposed systematic review aims to fill this gap by characterising comprehensively gonorrhoea infection in infertile populations globally. Methods and analysis All available studies of gonorrhoea infection in infertile populations, including infertility clinic attendees, will be systematically reviewed informed by Cochrane Collaboration guidelines. Findings will be reported following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Data sources will be searched using broad index terms exploded to cover all subheadings and free text terms with no language or year restriction. Any epidemiological measure in infertile populations based on primary data will be eligible for inclusion. Measures based on different assay types will be extracted as separate studies for different analyses. Only one biospecimen type per assay type will be considered based on a predefined priority order. Samples including fewer than 10 participants or assessing infection in the upper genital tract will be excluded. Quality assessments will be conducted for all measures included in the review. Meta-analyses will be implemented using DerSimonian-Laird random effect models to estimate the mean prevalence of gonorrhoea in infertile populations globally, and stratified by WHO region, assay type, sex, infertility type, infertility diagnosis, among other factors. Detailed heterogeneity assessment will be performed, and potential sources of between-study heterogeneity will be explored using meta-regression. Review will be conducted from 26 March 2018 to 28 July 2019. Ethics and dissemination An institutional review board clearance is not required as all data are publicly available. The findings will be disseminated through a peer-reviewed publication and international scientific meetings/workshops with key stakeholders. PROSPERO registration number CRD42018102934

KW - epidemiology

KW - Gonorrhea

KW - infertility

KW - Neisseria gonorrhoeae

KW - prevalence

KW - sexually transmitted infections

UR - http://www.scopus.com/inward/record.url?scp=85066337331&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85066337331&partnerID=8YFLogxK

U2 - 10.1136/bmjopen-2018-025808

DO - 10.1136/bmjopen-2018-025808

M3 - Review article

VL - 9

JO - BMJ Open

JF - BMJ Open

SN - 2044-6055

IS - 5

M1 - e025808

ER -